Prevention of Graft‐versus‐Host Disease
- 17 December 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 770 (1) , 149-164
- https://doi.org/10.1111/j.1749-6632.1995.tb31052.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A TOXICITY STUDY OF TRIMETREXATE USED IN COMBINATION WITH CYCLOSPORINE AS ACUTE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN HLA-MISMATCHED, RELATED DONOR BONE MARROW TRANSPLANTSTransplantation, 1995
- STUDIES OF THE USE OF L-LEUCYL-L-LEUCINE METHYL ESTER IN CANINE ALLOGENEIC MARROW TRANSPLANTATIONTransplantation, 1993
- SUCCINYL ACETONE PLUS METHOTREXATE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN DLA-HAPLOIDENTICAL CANINE LITTERMATE MARROW GRAFTSTransplantation, 1992
- Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphomaHuman Immunology, 1990
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- COMBINED IMMUNOSUPPRESSION WITH CYCLOSPORINE AND METHOTREXATE IN DOGS GIVEN BONE MARROW GRAFTS FROM DLA-HAPLOIDENTICAL LITTERMATESTransplantation, 1984
- Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsNew England Journal of Medicine, 1983
- RESCUE FROM CANINE GRAFT-VERSUS-HOST REACTION BY AUTOLOGOUS OR DL-A-COMPATIBLE MARRO,WTransplantation, 1974
- TREATMENT OF CANINE GRAFT-VERSUS-HOST DISEASE WITH METHOTREXATE AND CYCLOPHOSPHAMIDE FOLLOWING BONE MARROW TRANSPLANTATION FROM HISTOINCOMPATIBLE DONORSTransplantation, 1970